WP
TYRA icon

Woodline Partners’s Tyra Biosciences TYRA Stock Holding History

Woodline Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
320,040
+19,000
+6% +$629K 0.03% 532
2026
Q1 		$11.5M Buy
+301,040
New +$9.75M 0.04% 475
2025
Q3 		– Sell
-100,108
Closed -$958K – 1054
2025
Q2 		$958K Hold
100,108
– – 0.01% 808
2025
Q1 		$931K Buy
+100,108
New +$1.3M 0.01% 770
2024
Q4 		– Sell
-55,866
Closed -$1.31M – 1004
2024
Q3 		$1.31M Sell
55,866
-32,790
-37% -$688K 0.01% 496
2024
Q2 		$1.42M Buy
+88,656
New +$1.53M 0.01% 442
2023
Q4 		– Sell
-410,435
Closed -$5.65M – 660
2023
Q3 		$5.65M Hold
410,435
– – 0.07% 302
2023
Q2 		$6.99M Hold
410,435
– – 0.08% 255
2023
Q1 		$6.6M Buy
410,435
+111,419
+37% +$1.33M 0.09% 252
2022
Q4 		$2.27M Buy
299,016
+57,917
+24% +$410K 0.03% 460
2022
Q3 		$2.12M Sell
241,099
-48,073
-17% -$440K 0.03% 449
2022
Q2 		$2.07M Buy
289,172
+23,011
+9% +$183K 0.03% 416
2022
Q1 		$2.85M Buy
266,161
+1,416
+0.5% +$16.8K 0.05% 332
2021
Q4 		$3.73M Sell
264,745
-101,290
-28% -$2.01M 0.05% 326
2021
Q3 		$6.44M Buy
+366,035
New +$7M 0.11% 224

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Woodline Partners's TYRA Position: Q2 2026 in Review

Woodline Partners increased its Tyra Biosciences (TYRA) stake by 6.3% in Q2 2026, buying an estimated $629K and bringing the position to 320,040 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #532.

Woodline Partners first reported a position in TYRA in Q3 2021 and has held it in 15 quarters since. The position peaked at $11.5M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Woodline Partners held 320,040 shares of Tyra Biosciences worth $10.2M as of Q2 2026.
  • Woodline Partners bought 19,000 Tyra Biosciences shares in Q2 2026, an estimated $629K.
  • Tyra Biosciences made up 0.03% of Woodline Partners's portfolio in Q2 2026, its #532 holding.
  • Woodline Partners first reported a position in Tyra Biosciences in Q3 2021 and has held it in 15 quarters since.
  • Woodline Partners's Tyra Biosciences position peaked at $11.5M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.